col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


62 Ergebisse       Seite 1

 [1] 
Bentham Science: Current Topics in Medicinal Chemistry
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Jan―08 A Comprehensive Review of mRNA-based Vaccines for COVID-19, A New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges Pegah Vosoughi, Seyed Morteza Naghib, Mehdi Rahmanian, M. R. Mozafari
2 [GO] 2024―Aug―28 Catalase: A Potential Pharmacologic Target for Hydrogen Peroxide in the Treatment of COVID-19 Aleksandr Urakov, Natalya Urakova, Aleksey Reshetnikov, Aleksey Shklyaev, Vladimir Nikolenko, Anatoly Osipov, et al. (+5)
3 [GO] 2024―Jun―10 A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management Vishal Chavda, Dhananjay Yadav, Harisinh Parmar, Raxit Brahmbhatt, Bipin Patel, Kajal Madhwani, et al. (+3)
4 [GO] 2024―Feb―22 Repurposing of Plant-based Antiviral Molecules for the Treatment of COVID-19 Jabeena Khazir, Rakesh Kr Thakur, Sajad Ahmed, Manzoor Hussain, Sumit G. Gandhi, Sadhana Babbar, et al. (+7)
5 [GO] 2024―Feb―06 Combating COVID-19 Crisis using Artificial Intelligence (AI) Based Approach: Systematic Review Kavya Singh, Navjeet Kaur, Ashish Prabhu
6 [GO] 2023―Okt―19 Antiviral Effects and Mechanisms of Green Tea Catechins on Influenza: A Perception on Combating Symptoms from COVID-19 Gene Chi Wai Man, Xu Zheng, Sze Wan Hung, Loucia Kit Ying Chan, Tao Zhang, Xiaoyan Chen, et al. (+5)
7 [GO] 2023―Aug―30 Natural Products: A Potential New Hope to Defeat Post-Acute Sequelae of COVID-19 Shuang Zhao, Aliya Abdurehim, Yu Yuan, Tan Yang, Chao Li, Yanqing Zhang, et al. (+3)
8 [GO] 2023―Aug―25 A Critical Assessment of COVID-19 Genomic Vaccines Dima A. Sabbah, Rima Hajjo, Suhair Sunoqrot
9 [GO] 2023―Apr―14 SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research Edeildo Ferreira da Silva-Júnior, Weslany Souza Rocha, Peng Zhan
10 [GO] 2023―Mrz―28 Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective Praveen Kumar Verma, Varun Aggarwal, Ekta Bala, Pawan Kumar, Pankaj Raizada, Pardeep Singh
11 [GO] 2023―Feb―23 Investigating Biomarkers for COVID-19 Morbidity and Mortality Marco Fiore, Flavio Maria Ceci, Giampiero Ferraguti, Marco Lucarelli, Antonio Angeloni, Enea Bonci, et al. (+12)
12 [GO] 2023―Jan―31 Contributions of Medicinal Chemistry During the Pandemic of Covid-19 Shampa Ghosh, Jitendra Kumar Sinha
13 [GO] 2023―Jan―27 SAR Based Review on Diverse Heterocyclic Compounds with Various Potential Molecular Targets in the Fight against Covid-19: A Medicinal Chemist Perspective Mohammad Mumtaz Alam, Anish Madan, Mansi Garg, Garvit Satija, Barkha Sharma, M Shaquiquzzaman, et al. (+6)
14 [GO] 2022―Dez―27 Piezoelectric biosensors and nanomaterials-based therapeutics for coronavirus and other viruses: A Mini-review Rakesh Bhaskar, Madeshwaran Sekkarapatti Ramasamy, Sung Soon Han
15 [GO] 2022―Dez―26 Probing the neuro-psychological changes observed with the administration of COVID-19 Drugs Indranath Chatterjee, Videsha Bansal
16 [GO] 2022―Dez―06 The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area Zhongji Meng
17 [GO] 2022―Dez―06 An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors Dima A. Sabbah
18 [GO] 2022―Dez―02 Repurposing of chemotherapeutics to combat COVID-19 Anil Kumar Saxena, Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede
19 [GO] 2022―Nov―04 Structure Based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design. Anusuya Shanmugam, Anbazhagan Venkattappan, M. Michael Gromiha
20 [GO] 2022―Okt―24 Exploring the targets of novel corona virus and docking-based screening of potential natural inhibitors to combat COVID-19 Asmita Samadder, Sisir Nandi, Rishita Dey
21 [GO] 2022―Okt―18 Therapeutic Targets and Computational Approaches on Drug Development for COVID-19 Anusuya Shanmugam
22 [GO] 2022―Okt―18 Effective Chemicals against Novel Coronavirus (COVID-19) in China Wei Liu
23 [GO] 2022―Okt―18 Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China Zhang Qi
24 [GO] 2022―Okt―18 Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery Ariane Sternberg
25 [GO] 2022―Aug―03 Coronavirus Disease COVID-19: A New Threat to Public Health
26 [GO] 2022―Jul―27 Host Cell Proteases Mediating SARS-CoV-2 Entry: An Overview. Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Nouhaila Ait Lahcen, Didier Villemin, Rachid Daoud, et al. (+2)
27 [GO] 2022―Jul―17 The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area Meng, ZJ
28 [GO] 2022―Jul―07 Therapeutics for the management of cytokine release syndrome in COVID-19 Shampa Ghosh, Shantanu Durgvanshi, Sung Soo Han, Rakesh Bhaskar, Jitendra Kumar Sinha
29 [GO] 2022―Jul―07 Novel Therapeutic Strategies for the Management of Neuropathology and Neuroprotection in COVID-19 Cindy Bandala
30 [GO] 2022―Mai―17 COVID-19 in G6PD-deficient patients, oxidative stress, and neuropathology Beatriz Hernández-Ochoa, Daniel Ortega-Cuellar, Abigail González-Valdez, Noemí Cárdenas-Rodríguez, Julieta Griselda Mendoza-Torreblanca, Itzel Jatziri Contreras-García, et al. (+3)
31 [GO] 2022―Mai―07 Mental disorders and poor COVID-19 prognosis: reevaluating the relationship through Ca2+/cAMP signalling Leandro Bueno Bergantin
32 [GO] 2022―Apr―27 A Review of Computational Approaches Targeting SARS-CoV-2 Main Protease to the Discovery of New Potential Antiviral Compounds Juan A. Castillo-Garit, Yudith Cañizares-Carmenate, Hai Pham-The, Virginia Pérez-Doñate, Francisco Torrens, Facundo Pérez-Giménez
33 [GO] 2022―Apr―06 Potential Neuroprotective Effect of Cannabinoids in Covid-19 Patients. José Luis Cortes-Altamirano, Ariadna Yáñes-Pizaña, Samuel Reyes-Long, González-Maciel Angélica, Cindy Bandala, Herlinda Bonilla-Jaime, Alfonso Alfaro-Rodríguez
34 [GO] 2022―Apr―03 Vitamin D and its possible relationship to neuroprotection in COVID-19: evidence in the literature Saray Quintero-Fabián, Cindy Bandala, Luz Adriana Pichardo-Macías, Itzel Jatziri Contreras-García, Saúl Gómez-Manzo, Beatriz Hernández-Ochoa, et al. (+3)
35 [GO] 2022―Mrz―08 BIBLIOMETRIC ANALYSIS: NANOTECHNOLOGY AND COVID-19 Claure Nain Lunardi, Fernanda Lima Subrinho, Mirella Paula de Freitas Barros, Raiane Cavalcante Lima, Ana Clara Magalhaes de Queiroz Melo, Daniela de Melo Barbosa, et al. (+6)
36 [GO] 2022―Mrz―04 HDAC inhibition as neuroprotection in COVID-19 infection Yudibeth Sixto-López, José Correa-Basurto
37 [GO] 2021―Jul―28 Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment Harekrishna Roy, Asha Gummadi, Bhabani Shankar Nayak, Sisir Nandi, Anil Kumar Saxena
38 [GO] 2021―Jul―19 Protease Inhibitors as Promising Weapons against COVID-19: Focus on Repurposing of Drugs Used to Treat HIV and HCV infections Luciana Jesus da Costa, Matheus Mendonça Pereira, Lívia de Souza Ramos, Thaís Pereira de Mello, Laura Nunes Silva, Marta Helena Branquinha, André Luis Souza dos Santos
39 [GO] 2021―Jun―19 Chimeric virus-like particles of universal antigen epitopes of coronavirus and phage Qβ coat protein trigger the production of neutralizing antibodies Yukun Guo, Ruizhen Guo, Yingxian Ma, Wenru Chang, Shengli Ming, Guoyu Yang, Yujie Guo
40 [GO] 2021―Jun―15 COVID-19 and diabetes mellitus: potential metabolic associations Pedro Henrique Abreu da Silva, Andressa Santos Garcia, Fábio Aguiar Alves, André Luis Souza dos Santos, Cátia Lacerda Sodré
41 [GO] 2021―Mai―13 The effect of recombinant human interferon alpha nasal drops to prevent COVID-19 pneumonia for medical staff in an epidemic area Zhongji Meng, Tongyu Wang, Li Chen, Xinhe Chen, Longti Li, Xueqin Qin, et al. (+2)
42 [GO] 2021―Mrz―31 Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance Gabriela Seabra, Roberta Ferreira Ventura Mendes, Luiz Felipe Vieira dos Santos Amorim, Ingrid Vianez Peregrino, Marta Helena Branquinha, André Luis Souza dos Santos, Ana Paula Ferreira Nunes
43 [GO] 2021―Jan―19 An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong
44 [GO] 2020―Dez―08 An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong
45 [GO] 2020―Nov―13 Recent Advances in Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses Arti Sharma, Kajal Kaliya, Sushil K. Maurya
46 [GO] 2020―Nov―03 Most Promising Compounds for Treating COVID-19 and Recent Trends in Antimicrobial & Antifungal Agents Anuraj Nayarisseri
47 [GO] 2020―Okt―01 Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic Mohamed Abouleish, Ali El-Keblawy, Kareem A. Mosa, Sameh S.M. Soliman
48 [GO] 2020―Okt―01 Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options Laura Nunes Silva, Thaís Pereira de Mello, Lívia de Souza Ramos, Marta Helena Branquinha, Maryam Roudbary, André Luis Souza dos Santos
49 [GO] 2020―Sep―23 Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2 Satya P. Gupta
50 [GO] 2020―Jul―20 COVID-19: Small-Molecule Clinical Trials Landscape Leonardo L.G. Ferreira, Adriano D. Andricopulo
51 [GO] 2020―Jul―17 Ligand- and structure-based virtual screening of Lamiaceae diterpenes with potential activity against a novel coronavirus (2019-nCoV) Gabriela Cristina Soares Rodrigues, Mayara dos Santos Maia, Renata Priscila Barros de Menezes, Andreza Barbosa Silva Cavalcanti, Natália Ferreira de Sousa, Érika Paiva de Moura, et al. (+3)
52 [GO] 2020―Jul―16 Therapeutic targets and computational approaches on drug development for COVID-19 Anusuya Shanmugam, Nisha Muralidharan, D. Velmurugan, M. Michael Gromiha
53 [GO] 2020―Jul―04 Shape-based Machine Learning Models for the potential Novel COVID-19 protease inhibitors assisted by Molecular Dynamics Simulation. Ravina Khandelwal, Anuraj Nayarisseri, Maddala Madhavi, Chandrabose Selvaraj, Umesh Panwar, Khushboo Sharma, et al. (+2)
54 [GO] 2020―Mai―19 The Evolution of Computational Chemistry Along with Coronaviruses Weng Ieong Tou, Kuok Wa Tam, Hou Ng
55 [GO] 2020―Mai―17 Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery Ariane Sternberg, Dwight L. McKee, Cord Naujokat
56 [GO] 2020―Mai―12 COVID-19 Pandemic - Are We Heading From Health Crisis Towards An Unprecedented Nutrition Crisis? Yogesh Kumar, Akanksha Jain
57 [GO] 2020―Mai―12 COVID-19: An Update on Clinical Trials Yogesh Kumar, Anil Kumar Singh, Shiv Kumar
58 [GO] 2020―Mai―12 Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China Zhang Qi, Yu Yu
59 [GO] 2020―Apr―13 Coronavirus Disease (COVID-19) Pandemic: A Race Against Time Amit Kumar Banerjee, Neelima Arora
60 [GO] 2020―Mrz―05 Effective Chemicals against Novel Coronavirus (COVID-19) in China Wei Liu, Hai-liang Zhu, Yongtao Duan
61 [GO] 2020―Mrz―05 Coronavirus Disease COVID-19: A New Threat to Public Health Sumit Kumar, Brijesh Rathi
62 [GO] 2020―Mrz―05 China Coronavirus Outbreak: All the Latest Updates Luciana Scotti, Marcus T. Scotti
 [1] 

62 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.010 sec